Table 2.
Treatment Characteristics
| Variable (n = 141) | Median (IQR 25, 75) | Range |
|---|---|---|
| Treatment angiosome volume (mL) | 215 (115, 381) | (30–1410) |
| Whole liver volume (mL) | 1698 (1362, 2094) | (707–3610) |
| Percent liver treated (%) | 12.6 (7.3, 21.7) | (1.3–69.0) |
| Total MIRD dose (Gy) | 403 (303, 522) | (190–1110) |
| Treatment activity (GBq) | 1.67 (0.94, 2.84) | (0.23–8.00) |
| Lung dose (Gy) | 1.31 (0.66, 3.17) | (0.10–30.90) |
| Lung shunt fraction (%) | 1.6 (1.0, 2.8) | (0.1–23.3) |
| Total sphere number (million) | 4.0 (2.4, 6.0) | (1.2–16.6) |
| Specific activity (Bq) | 527 (319, 700) | (145–2009) |
| Spheres per cc (thousands) | 17 (13, 26) | (3–67) |
Abbreviations: IQR, interquartile range; MIRD, Medical Internal Radiation Dose.